Mene Pangalos, AstraZeneca R&D chief (AstraZeneca via YouTube)
AstraZeneca and Sanofi tout breakthrough in €645M alliance against leading cause of infant death
After 23 years, a new treatment for one of the leading causes of infant death may be on the horizon.
AstraZeneca and Sanofi announced Monday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
